NUP205新发截短突变是早发性卵巢功能不全的关键因素
该研究对一个特发性早发性卵巢功能不全(POI)家系行全外显子测序,发现NUP205新发杂合无义突变c.3160C>T(p.R1054*),并在1030例POI队列中检出另外5个家系携带NUP205变异。体外COV434细胞和体内斑马鱼模型的功能验证显示NUP205缺陷导致核孔复合体结构异常、卵子发生受损和生育力下降,提示NUP205是POI的关键致病基因。
要点
- NUP205新发截短突变c.3160C>T(p.R1054*)在POI家系中与疾病共分离。
- 1030例POI队列中另检出5个家系携带NUP205变异(3个杂合、2个复合杂合)。
- NUP205缺陷致核孔复合体结构异常、卵子发生受损和生育力下降。
核心结论
- NUP205对卵巢发育至关重要,其缺陷是POI发病的关键因素。
- NUP205是POI新的遗传致病基因,扩展了核孔蛋白相关生殖障碍谱系。
研究设计与样本
- 多层面遗传与功能研究:先对POI家系行全外显子测序,再在1030例POI队列中重筛NUP205变异。
- 功能验证采用体外COV434细胞系和体内CRISPR/Cas9构建的nup205(p.R1057*)截短斑马鱼模型。
主要发现
- 先证家系检出NUP205新发杂合无义突变c.3160C>T(p.R1054*),公共基因组数据库未见该变异。
- 扩大筛查在1030例POI队列中另发现5个家系携带NUP205变异(3个杂合、2个复合杂合),均累及高度保守残基。
- COV434细胞中NUP205敲低损害NUP93和NUP62蛋白稳定性,最终导致核孔复合体结构缺陷。
- 携带等效nup205(p.R1057*)突变的斑马鱼表现为卵子发生受损、生育力下降和受精率降低。
- 透射电镜显示突变斑马鱼卵泡膜细胞中核孔复合体形态异常。
关键数值与推荐
- 候选变异依据美国医学遗传学与基因组学学会(ACMG)指南进行优先级排序。
- NUP205在卵泡中的表达通过公共卵巢单细胞RNA测序数据集重分析确定,并经人卵巢组织免疫荧光确认。
临床怎么用
- 对特发性POI患者可考虑NUP205基因检测,尤其家系中呈新发显性遗传模式者。
- NUP205变异检出可为POI遗传咨询和病因诊断提供依据。
局限性
- 虽在大型POI队列中检出额外NUP205变异,但这些特定变异的详细分子机制仍待进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does nucleoporin 205 (NUP205) deficiency caused by a novel de novo truncation mutation underlie the pathogenesis of premature ovarian insufficiency (POI)? SUMMARY ANSWER: NUP205 plays a critical role in ovarian development, and mutations in NUP205 represent a key factor in the pathogenesis of POI. WHAT IS KNOWN ALREADY: POI is a highly heterogeneous disorder with a significant genetic basis. The nuclear pore complex (NPC) is a fundamental channel mediating nucleocytoplasmic transport, with NUP205 serving as a key scaffold component of the NPC. STUDY DESIGN, SIZE, DURATION: This study employed a multilevel genetic and functional investigation, starting with whole-exome sequencing (WES) of a POI pedigree. Clinical significance was further assessed through a large-scale cohort involving 1030 POI cases. Functional validation was performed using the in vitro human cell line COV434 and an in vivo zebrafish model. PARTICIPANTS/MATERIALS, SETTING, METHODS: A Chinese family with idiopathic POI was recruited. To evaluate the clinical prevalence of NUP205 variants, WES data from a previously published cohort of 1030 POI cases were rescreened. Candidate variants were prioritized based on American College of Medical Genetics and Genomics guidelines and the functional impact of the identified mutation was further evaluated through protein structural modeling. The expression of NUP205 in follicles was determined by reanalyzing public ovarian single-cell RNA sequencing datasets and confirmed via immunofluorescence on human ovarian tissues. Functional assays were performed through siRNA-mediated knockdown in COV434 cells, complementing phenotypic and ultrastructural analyses of a CRISPR/Cas9-generated nup205 (p.R1057*) truncation zebrafish model. MAIN RESULTS AND THE ROLE OF CHANCE: A novel heterozygous nonsense mutation in NUP205 c.3160C>T (p.R1054*) was identified in the index pedigree, which was absent in public genomic databases. Expanded screening of the cohort identified five additional families carrying NUP205 variants (three heterozygous and two compound heterozygous) affecting highly conserved residues. In vitro, NUP205 knockdown in COV434 cells impaired the protein stability of NUP93 and NUP62, ultimately leading to NPC structural defects. In vivo, a zebrafish model carrying the equivalent nup205 (p.R1057*) mutation exhibited impaired oogenesis, compromised fertility, and lower fertilization rates. Transmission electron microscopy revealed abnormal NPC morphology in the theca cells of the mutant follicles. These findings demonstrate that NUP205 is essential for ovarian development and suggest that its deficiency is a key factor in POI pathogenesis, indicating that the observed association is unlikely to be due to chance. LIMITATIONS, REASONS FOR CAUTION: Although we identified additional NUP205 variants in a large POI cohort, the detailed molecular mechanisms of these specific variants remain to be further investigated. WIDER IMPLICATIONS OF THE FINDINGS: These findings identify NUP205 as a novel genetic contributor to POI, expanding the spectrum of nucleoporin-related reproductive disorders. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Natural Science Foundation of China (U24A20659 and 82500964). The authors declare that they have no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Cai S, Li H, Ma X, et al. A de novo C-terminal truncation mutation in NUP205 as a key factor in premature ovarian insufficiency. Hum Reprod. 2026. PMID: 42049205. doi:10.1093/humrep/deag068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。